Intrinsic Value of S&P & Nasdaq Contact Us

American Well Corporation AMWL NYSE

NYSE • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
40/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.00
-9.3%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

American Well Corporation (AMWL) has a negative trailing P/E of -1.0, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -101.75%.

Criteria proven by this page:

  • VALUE (73/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
  • Trailing Earnings Yield -101.75% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
  • Analyst consensus target $5.00 (-9.3% downside) — slight downside risk — the market may be ahead of analyst expectations.

Overall SharesGrow Score: 40/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
40/100
SG Score
View full scorecard →
VALUE
73/100
Price-to-Earnings & upside
Proven by this page
FUTURE
26/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
58/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — AMWL

Valuation Multiples
P/E (TTM)-1.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.40
P/S Ratio0.38
EV/EBITDA1.2
Per Share Data
EPS (TTM)$-5.84
Book Value / Share$15.11
Revenue / Share$15.20
FCF / Share$-4.02
Yields & Fair Value
Earnings Yield-101.75%
Dividend Yield0.00%
Analyst Target$5.00 (-9.3%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2018 -17.8 0.00 2.72 8.22 -
2019 -10.9 -0.17 2.72 6.38 -
2020 -11.2 -1.62 2.05 10.23 -
2021 -8.7 0.13 1.24 6.07 -
2022 -2.9 -0.07 0.73 2.80 -
2023 -0.6 0.00 0.91 1.64 -
2024 -0.5 0.01 0.36 0.43 -
2025 -0.8 0.01 0.33 0.32 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2018 $-25.96 $113.96M $-52.67M -46.2%
2019 $-42.96 $148.86M $-88.37M -59.4%
2020 $-45.72 $245.27M $-226.44M -92.3%
2021 $-13.67 $252.79M $-173.65M -68.7%
2022 $-19.68 $277.19M $-269.79M -97.3%
2023 $-47.50 $259.05M $-675.16M -260.6%
2024 $-13.88 $254.36M $-208.14M -81.8%
2025 $-5.96 $249.33M $-95.7M -38.4%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-4.30 $-4.52 – $-4.17 $199.58M $198.99M – $200.18M 3
2027 $-3.22 $-3.37 – $-3.12 $207.81M $200.34M – $219.12M 2
2028 $-2.13 $-2.45 – $-1.74 $217.56M $217.56M – $217.56M 3
2029 $-1.16 $-1.21 – $-1.12 $217.23M $212.21M – $225.51M 1
2030 $-0.98 $-1.02 – $-0.95 $227.61M $222.35M – $236.29M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message